STAT+: Europe will accelerate its review of RevMed’s drug

Bryan Johnson’s chronic disease is notoriously difficult to diagnose

STAT+: Prime Medicine claims victory in dispute over gene-editing technology with Beam Therapeutics

Biohacker Bryan Johnson Diagnosed with Incurable Autoimmune Gastritis

Bryan Johnson, the tech entrepreneur and longevity advocate known for his extreme $2 million/year health regimen, has been diagnosed with au

STAT+: FDA approves Vera Therapeutics kidney disease treatment

STAT+: The crumbling employer-based health insurance system

Cancer therapy spinout Myricx Bio agrees to US$1.5B acquisition by Novartis

Myricx Bio, a cancer therapy spinout from the Francis Crick Institute and Imperial College London, has agreed to be acquired by Novartis in